eFFECTOR Therapeutics, Inc.
EFTRDelisted Jul 19, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828522
eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in eFFECTOR Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +1 vs. Q4 2021
- Shares held
- 22.5M
- +1.07M (+5.0%) vs. Q4 2021
- Total value
- $89.7M
- −$84.5M (−48.5%) vs. Q4 2021
- New holders
- 3
- 5 more added
- Sold out
- 2
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EFTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 3 | $4.33K |
| Q2 2024 | 18 | $251.1K |
| Q1 2024 | 17 | $13.5M |
| Q4 2023 | 24 | $5.44M |
| Q3 2023 | 29 | $14.0M |
| Q2 2023 | 33 | $20.2M |
| Q1 2023 | 26 | $8.29M |
| Q4 2022 | 30 | $10.4M |
| Q3 2022 | 27 | $13.7M |
| Q2 2022 | 24 | $33.9M |
| Q1 2022 | 19 | $89.7M |
| Q4 2021 | 18 | $174.2M |
| Q3 2021 | 12 | $187.9M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding eFFECTOR Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sr One Capital Management, LP | 6,822,114 | $27.4M | 14.01% | 00.0% | Unchanged |
| Abingworth LLP | 4,822,114 | $18.9M | 5.36% | 00.0% | Unchanged |
| The Column Group LLC | 4,309,329 | $17.3M | 3.20% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 2,382,744 | $9.55M | 1.70% | 00.0% | Unchanged |
| Blackstone Group Inc. | 1,308,587 | $5.25M | 0.01% | 00.0% | Unchanged |
| OUP Management Co., LLC | 1,025,697 | $4.11M | 3.13% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 677,452 | $2.74M | 0.11% | +677,452 | New |
| Vanguard Group Inc | 516,798 | $2.07M | 0.00% | +634+0.1% | Added |
| Norges Bank | 416,300 | $1.67M | 0.00% | +416,300 | New |
| Geode Capital Management, LLC | 106,346 | $426.0K | 0.00% | +10,545+11.0% | Added |
| Alps Advisors Inc | 46,537 | $187.0K | 0.00% | −5,405−10.4% | Reduced |
| State Street Corp | 17,000 | $68.0K | 0.00% | +17,000 | New |
| Northern Trust Corp | 16,745 | $67.0K | 0.00% | +88+0.5% | Added |
| Penserra Capital Management LLC | 3,620 | $14.0K | 0.00% | +617+20.5% | Added |
| BlackRock Inc. | 1,133 | $4.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 548 | $2.00K | 0.00% | −189−25.6% | Reduced |
| UBS Group AG | 141 | $1.00K | 0.00% | −2,260−94.1% | Reduced |
| Morgan Stanley | 61 | $0 | 0.00% | −28,617−99.8% | Reduced |
| Wells Fargo & Company | 60 | $0 | 0.00% | +1+1.7% | Added |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −14,122−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −780−100.0% | Sold out |